Stock Events

Stock Events

Vistin Pharma ASA 

€1.7100
0
-€0.03-1.72% Tuesday 14:32

Statistics

Day High
1.755
Day Low
1.71
52W High
2.12
52W Low
1.24
Volume
-
Avg. Volume
-
Mkt Cap
75.83M
P/E Ratio
-
Dividend Yield
10.83%
Dividend
0.19

Upcoming

Dividends

10.83%Dividend Yield
May 26
€0.09
Jun 25
€0.11
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
-14.63%

Financials

16.55%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
38.72MRevenue
6.41MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow VP4.STU. It's not an investment recommendation.
Equinor ASA
4
EQNR.OL
Yara International ASA.
4
YAR.OL
Kongsberg Gruppen ASA
3
KOG.OL
Norsk Hydro ASA
3
NHY.OL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novo Nordisk
NVO
Mkt Cap190.32B
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This competes directly with Vistin Pharma's focus on pharmaceuticals and medical solutions.
Pfizer
PFE
Mkt Cap157.99B
Pfizer is a global biopharmaceutical company that produces medicines and vaccines for a wide range of medical disciplines, including areas where Vistin Pharma operates.
Merck
MRK
Mkt Cap355.1B
Merck & Co., Inc. provides healthcare solutions that include pharmaceutical, vaccines, biologic therapies, and animal health products, competing in the pharmaceuticals sector with Vistin Pharma.
Astrazeneca
AZN
Mkt Cap248.41B
AstraZeneca is a multinational pharmaceutical and biopharmaceutical company with a wide range of products in various therapeutic areas, competing with Vistin Pharma in the pharmaceutical market.
GSK
GSK
Mkt Cap96.43B
GlaxoSmithKline is a global healthcare company that researches, develops, and manufactures innovative pharmaceutical medicines, vaccines, and consumer healthcare products, competing with Vistin Pharma.
Johnson & Johnson
JNJ
Mkt Cap640.02B
Johnson & Johnson is a multinational corporation that produces pharmaceuticals, medical devices, and consumer packaged goods, directly competing with Vistin Pharma in the healthcare sector.
Sanofi
SNY
Mkt Cap102.48B
Sanofi is a global biopharmaceutical company focused on human health, offering a broad range of medicines and vaccines, which puts it in competition with Vistin Pharma.
Abbvie
ABBV
Mkt Cap454.36B
AbbVie is a research-based biopharmaceutical company that develops and markets advanced therapies, competing with Vistin Pharma in the pharmaceutical and healthcare market.
Bristol-Myers Squibb
BMY
Mkt Cap130B
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases, competing with Vistin Pharma.
Novartis
NVS
Mkt Cap260.7B
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide, competing with Vistin Pharma in various therapeutic areas.

About

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin APIs and direct compressive granulates for the pharmaceutical industry. The company was incorporated in 2015 and is headquartered in Oslo, Norway.
Show more...
CEO
Mr. Kjell-Erik Nordby
Country
Other
ISIN
NO0010734122
WKN
000A14TLR

Listings

ST
SE
VISTINO.ST
STU
DE
VP4.STU
LSE
GB
0RAM.LSE
OL
NO
VISTN.OL

0 Comments

Share your thoughts

FAQ

What is Vistin Pharma ASA stock price today?▼
The current price of VP4.STU is €1.71 EUR — it has decreased by -1.72% in the past 24 hours. Watch Vistin Pharma ASA stock price performance more closely on the chart.
What is Vistin Pharma ASA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Vistin Pharma ASA stocks are traded under the ticker VP4.STU.
Is Vistin Pharma ASA stock price growing?▼
VP4.STU stock has fallen by -4.2% compared to the previous week, the month change is a -6.3% fall, over the last year Vistin Pharma ASA has showed a -13.42% decrease.
What is Vistin Pharma ASA market cap?▼
Today Vistin Pharma ASA has the market capitalization of 75.83M
What is Vistin Pharma ASA revenue for the last year?▼
Vistin Pharma ASA revenue for the last year amounts to 38.72M EUR.
What is Vistin Pharma ASA net income for the last year?▼
VP4.STU net income for the last year is 6.41M EUR.
Does Vistin Pharma ASA pay dividends?▼
Yes, VP4.STU dividends are paid semi-annual. The last dividend per share was 0.09 . As of today, Dividend Yield (FWD)% is 10.83%.
In which sector is Vistin Pharma ASA located?▼
Vistin Pharma ASA operates in the Energy sector.
When did Vistin Pharma ASA complete a stock split?▼
Vistin Pharma ASA has not had any recent stock splits.
Where is Vistin Pharma ASA headquartered?▼
Vistin Pharma ASA is headquartered in Oslo, Other.